Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Current Leases (2019 - 2025)

Assembly Biosciences (ASMB) has 7 years of Current Leases data on record, last reported at $548000.0 in Q3 2025.

  • For Q3 2025, Current Leases fell 58.77% year-over-year to $548000.0; the TTM value through Sep 2025 reached $548000.0, down 58.77%, while the annual FY2024 figure was $461000.0, 62.21% down from the prior year.
  • Current Leases reached $548000.0 in Q3 2025 per ASMB's latest filing, up from $533000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $3.4 million in Q3 2022 and bottomed at $461000.0 in Q4 2024.
  • Average Current Leases over 5 years is $2.0 million, with a median of $1.7 million recorded in 2023.
  • Peak YoY movement for Current Leases: tumbled 74.22% in 2023, then soared 52.93% in 2024.
  • A 5-year view of Current Leases shows it stood at $3.2 million in 2021, then rose by 6.76% to $3.4 million in 2022, then plummeted by 63.73% to $1.2 million in 2023, then plummeted by 62.21% to $461000.0 in 2024, then rose by 18.87% to $548000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $548000.0 in Q3 2025, $533000.0 in Q2 2025, and $529000.0 in Q1 2025.